^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    WJ05129

    i
    Other names: WJ05129, JS112
    Associations

    News

    Trials
    Company:
    Shanghai Junshi Biosci, Wigen Biomedicine
    Drug class:
    Aurora kinase A inhibitor
    Related drugs:
    Associations

    News

    Trials
    over2years
    A Study of WJ05129 in Advanced Malignant Solid Tumors (clinicaltrials.gov)
    P1/2, N=126, Not yet recruiting, Suzhou Junjing BioSciences Co., Ltd.
    New P1/2 trial
    |
    MYC (V-myc avian myelocytomatosis viral oncogene homolog)
    |
    MYC expression • RB1 negative
    |
    WJ05129